[Watch webinar recording] We welcome you to register for an exclusive media webinar on the latest WHO recommendations regarding shorter, cheaper and possibly better MDR-TB treatment regimen. Accurate and early diagnosis along with shorter, cheaper and more effective treatment can help countries deliver on their promises to end TB by 2030 or earlier (Sustainable Development Goal 3.3).
Experts from the World Health Organization (WHO)'s Global Tuberculosis Programme, International Union Against Tuberculosis and Lung Disease (The Union), and India's national TB programme (formally called Revised National TB Control Programme) will present and respond to questions live!
New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen. At less than US$ 1000 per patient, the new treatment regimen can be completed in 9 - 12 months. Not only is it less expensive than current regimens, but it is also expected to improve outcomes and potentially decrease deaths due to better adherence to treatment and reduced loss to follow-up.
Date: Tuesday, 21st June 2016
Time: 1:00pm Geneva Time, 12 noon London Time, 1pm Durban Time, 7:00am New York/ Boston Time, 4:30pm Indian Standard Time, 6pm Thailand time
(check www.timeanddate.com for your local time)
Duration: 60 minutes
To register, click here
About the Experts:
Experts from the World Health Organization (WHO)'s Global Tuberculosis Programme, International Union Against Tuberculosis and Lung Disease (The Union), and India's national TB programme (formally called Revised National TB Control Programme) will present and respond to questions live!
New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen. At less than US$ 1000 per patient, the new treatment regimen can be completed in 9 - 12 months. Not only is it less expensive than current regimens, but it is also expected to improve outcomes and potentially decrease deaths due to better adherence to treatment and reduced loss to follow-up.
Date: Tuesday, 21st June 2016
Time: 1:00pm Geneva Time, 12 noon London Time, 1pm Durban Time, 7:00am New York/ Boston Time, 4:30pm Indian Standard Time, 6pm Thailand time
(check www.timeanddate.com for your local time)
Duration: 60 minutes
To register, click here
About the Experts:
- [Presentation] Dr ID Rusen, Senior Vice President (Research and Development), International Union Against TB and Lung Disease (The Union), who leads the TREAT TB initiative which coordinated the STREAM clinical trials for shortened MDR-TB treatment regimen
- Dr Fuad Mirzayev, Medical Officer, Laboratories, Diagnostics and Drug Resistance unit, WHO Global TB Programme
- Dr Sunil Khaparde, Deputy Director General of Revised National TB Control Programme, Ministry of Health and Family Welfare, India
- Moderator: Ashok Ramsarup, noted award-winning commentator and senior radio programme producer, South African Broadcasting Corporation (SABC)
- Co-moderator: Shobha Shukla, Managing Editor, CNS (Citizen News Service)
To register, click here
CNS Webinars Team
Email: webinar@citizen-news.org
